IPIuri Barbosa Pereira

Iuri Barbosa Pereira

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Iuri Barbosa Pereira has a total of 9 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    A comprehensive study to compare different compound representations for predicting carcinogenicity in vivo

    by Iuri Pereira, Rogerio Salvini, Eloisa Dutra Caldas

    Carcinogenicity evaluation is a critical component of chemical risk assessment, yet traditional in vivo testing remains time-consuming, costly, and ethically challenging. Computational approaches based on machine learning offer promising alternatives, but the relative contribution of different molecular representation strategies for predicting in vivo carcinogenicity remains insufficiently explored. This study aimed to systematically evaluate the impact of molecular embeddings, classical descriptors, and toxicophore structural alerts on the performance of machine learning models for in vivo carcinogenicity prediction. A curated dataset of 2,090 distinct compounds tested exclusively in vivo was assembled by integrating five major toxicological databases. Compounds were represented using classical molecular descriptors, descriptor sets enriched with structural alerts, SMILES-derived molecular embeddings, and hybrid combinations of these representations. Twenty-four machine learning classifiers were benchmarked under a 10-fold stratified cross-validation protocol. Model performance was assessed using accuracy, precision, recall, F1-score, and AUC-ROC, with statistical significance evaluated using Friedman and Nemenyi tests. Results indicated that representations combining molecular descriptors with structural alerts tend to yield the most consistent predictive performance across models. Embeddings contribute as complementary features but do not replace classical representations. These findings reinforce the central role of chemically interpretable, expert-driven descriptors, particularly those incorporating genotoxic structural alerts, in regulatory-relevant carcinogenicity modeling.

  • Open Access

    Carbamazepine and carbamazepine-10, 11-epoxide therapeutic drug monitoring and biochemical and hematological evaluation in bipolar disorder outpatients

    by Luiz Carlos da Cunha, Ramias Vieira Calixto Freire, Carla Maria de Sousa Silva, Vania Cristina Rodriguez Salazar, Alessandro de Carvalho Cruz, Jerônimo Raimundo de Oliveira Neto, Renzo Freire de Almeida, Iuri Barbosa Pereira

    The objective of this study was to validate an analytical technique with HPLC-PDA for plasma measurement of carbamazepine (CBZ) and its metabolite carbamazepine-10, 11-epoxide (CBZ-E) for therapeutic monitoring (TM) of patients diagnosed with bipolar disorder (BD), as well as evaluating hematological and biochemical parameters of patients using CBZ. Sixteen patients registered with the Public Service of Psychiatry were selected. CBZ and CBZ-E measurements were performed with HPLC-PDA shimadzu LC-20 AT Prominence, under concentration gradient. Validation criteria: selectivity, linearity, precision, accuracy, recovery, stability. Hematological and biochemical tests were performed using conventional methods. As a result, it was obtained: accuracy >85% and precision <15%, good selectivity, robustness and stability, LOQ = 250 ng.mL-1 and HQL = 60,000 ng.mL-1. Among patients, 25% and 6.25% had CBZ and CBZ-E levels within the therapeutic range, respectively. There were hematological and biochemical changes related to the drug. The validated method is reliable for its intended purpose. TM proved to be extremely useful for detecting therapeutic failure.